论文部分内容阅读
4月6～9日在上海第二军医大学召开了全国羟基哌喹治疗矽肺研究总结会议,出席代表72人,中央卫生部卫生局及中华全国总工会保护部等单位派员出席了会议。羟基哌喹是4-氨基喹啉类抗疟药,由二军大研制合成,后来发觉此药对实验性矽肺有疗效,与上海市劳研所等单位协作攻关开始临床应用。协作单位遍及全国十五个省、市、自治区。经过663例矽肺(包括部分煤矽肺)临床观察,该药对矽肺患者咳嗽、气短、胸痛等呼吸道症状有显著改善,有效率达54～62%。具有疗效好、起效快、毒副反应轻微,服用方便等优点。 7月20～22日中国人民解放军总后勤部卫生部在沪主持召开了鉴定会.
From April 6 to April 9, the National Seminar on the Treatment of Silicosis with Hydroperoquine was held in the Second Military Medical University in Shanghai. Attendance was attended by 72 delegates, representatives from the Health Bureau of the Central Ministry of Health and the All-China Federation of Trade Unions, and other units attended the meeting. Hydroquinone is a 4-aminoquinoline antimalarial drug developed and synthesized by the Second Military Medical University. Later, it was found that the drug was effective on experimental silicosis and started clinical application in collaboration with the Shanghai Institute of Labor Research. Collaborative units throughout the country 15 provinces, municipalities and autonomous regions. After 663 cases of silicosis (including part of the coal silicosis) clinical observation, the drug on patients with silicosis cough, shortness of breath, chest pain and other respiratory symptoms have significantly improved, the effective rate of 54 to 62%. Has a good effect, rapid onset, mild side effects, taking advantage of convenience. From July 20 to July 22, the Ministry of Health of the General Logistics Department of the Chinese People’s Liberation Army held an appraisal meeting in Shanghai.